Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Prestige Consumer Healthcare to acquire Akorn’s brands for $230m
Prestige Consumer Healthcare has agreed to acquire specialty pharmaceuticals provider Akorn Operating Company’s Consumer Health business for approximately $230m.
Pharmaceuticals Healthcare
-
28 May 2021
-
17 Mar 2021
USFDA grants priority review to Merck’s NDA for HIF-2α inhibitor Belzutifan
The US Food and Drug Administration (FDA) has granted priority review for Merck’s New Drug Application (NDA) for the hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor belzutifan.